Down-regulation of FXYD3 expression in human lung cancers: its mechanism and potential role in carcinogenesis

Koji Okudela1, Takuya Yazawa, Jun Ishii

  • 1Department of Pathology, Yokohama City University Graduate School of Medicine, Kanazawa-Ku, Yokohama, Japan.

Insights

FXYD3 (FXYD domain-containing ion-transport associated protein 3) is downregulated in lung cancer, potentially contributing to cancer cell shape changes and progression. Its inactivation may be linked to gene mutations.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • FXYD3 (FXYD domain-containing ion-transport associated protein 3) is a regulator of Na,K-ATPase.
  • Initially identified as overexpressed in breast tumors, its role in lung cancer was unclear.
  • Preliminary data showed FXYD3 downregulation in KRAS-mutated lung cells.

Purpose of the Study:

  • Investigate the role of FXYD3 in lung carcinogenesis.
  • Determine FXYD3 expression levels in lung cancer.
  • Explore the functional impact of FXYD3 loss in lung cancer.

Main Methods:

  • Quantitative analysis of FXYD3 mRNA and protein in lung cancer cell lines and primary tumors.
  • Mutation analysis of the FXYD3 gene.
  • Functional assays involving forced expression of wild-type and mutant FXYD3.
  • Assessment of cytoskeletal organization (cortical actin distribution).
  • Analysis of FXYD3 promoter methylation status.

Main Results:

  • FXYD3 expression was significantly lower in most lung cancer cell lines and primary tumors compared to non-cancerous lung tissue.
  • Decreased FXYD3 levels correlated with tumor dedifferentiation.
  • A somatic mutation (g55c, D19H) was identified in one cell line.
  • Restoration of wild-type FXYD3, but not mutant, normalized cortical actin distribution in FXYD3-deficient cancer cells.
  • No association was found between FXYD3 expression and promoter methylation.

Conclusions:

  • FXYD3 inactivation, potentially via gene mutation or other mechanisms, may contribute to altered cell morphology in lung cancer.
  • FXYD3 plays a role in maintaining cytoskeletal integrity.
  • FXYD3 inactivation could be a factor in lung cancer progression.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...